Bio

As of September 1, 2022, I am Head of U.S. General Medicines at Sanofi. Previously, I was President of Sanofi France since March 2020. During my career at Merck KGaA, Amgen and Bristol-Myers Squibb, I held responsibilities in the areas of market access, in France and in Europe. In 2009, I was appointed Director of reserved matters for the Ile-de-France Regional Health Agency before joining, in 2011, the office of the French President as Adviser for health, dependence and social policies. In 2015, I joined Sanofi where I held various positions, including Deputy Head ''Global Policy,'' and since 2017, Chief of staff to Sanofi's Chief Executive Officer. In addition to my duties at Sanofi, I sit on the Board of Directors of Leem (Les Entreprises du Médicament) and chair the French Federation of Health Industries.